attention deficit hyperactivity disorder. Disturbance of activity and attention
Conditions
Interventions
Intervention 1: Intervention group: children treat with methylphenidate and pramipexole during 6 weeks. The starting dose of methylphenidate considered to be 0.3mg / kg in two divided doses and increa
Treatment - Drugs
Intervention group: children treat with methylphenidate and pramipexole during 6 weeks. The starting dose of methylphenidate considered to be 0.3mg / kg in two divided doses and increase to 1mg/kg bas
Treatment groups: children 6 weeks will be treated with methylphenidate and placebo. Placebo pill shape, color, smell and taste will be like pramipexole.
Sponsors
Research Devision, Ahvaz Jondishapoor Medical University
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Children 6-12 years old;Having diagnostic criteria and testing Connors. Exclusion criteria: medical conditions such as kidney failure and epilepsy;psychiatric disorders with a focus on DSM IV-TR; mental disability;history of seizures other than seizures associated with fever,need for dopaminergic drugs, levodopa, ranitidine, cimetidine
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attention Deficit Hyperactivity Disorder. Timepoint: Befor intervention- the end of second, fourth and sixth weeks of the study. Method of measurement: The Conner's parent rating scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactForough Riahi
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed